Pediatric Nephrology

, Volume 21, Issue 6, pp 820–827 | Cite as

Treatment of primary and secondary hypertension in children

  • Douglas M. SilversteinEmail author
  • Edward Champoux
  • Diego H. Aviles
  • V. Matti Vehaskari
Original Article


The incidence of pediatric hypertension (HTN) is increasing, mainly due to an increase in primary (essential) HTN, or PH. There are only a limited number of studies assessing the characteristics and treatment efficacy of PH versus secondary HTN (SH). We conducted a retrospective analysis of 158 pediatric patients (mean age: 10.8 years; sex ratio: 51.1% female, 48.9% male) with HTN of whom 34.4% had PH and 65.6% had SH. The vast majority were either African-American or Caucasian. Among all patients, therapy induced a significant decrease in systolic blood pressure (SBP) and diastolic BP (DBP) (both p<0.0001). SBP (p<0.0001) and DBP (p=0.002) declined significantly in PH patients. PH and SH patients with a body mass index (BMI) >95th percentile (%) had a significantly higher post-therapy SBP (both p<0.05) than those with a BMI <95th%. SBP declined similarly in PH patients treated with calcium-channel blockers (CCB) and angiotensin-converting enzyme inhibitors (ACEI). DBP declined only in PH patients treated with ACEI. SBP and DBP (both p<0.0001) declined significantly in SH patients. Post-therapy BP was similar in SH patients treated with either CCB or ACEI. Post-therapy SBP and DBP were significantly lower in SH patients than in PH patients; moreover, therapy induced a greater decline in SBP and DBP in the SH patients. Compared to PH patients, SH patients were twofold more likely to achieve a SBP less than the 95th% after therapy. We conclude that (1) significant lowering of BP with either CCB or ACEI is achievable in most children with HTN, and (2) SH patients respond better to therapy than those with PH.


Child Hypertension Primary Secondary Treatment 


  1. 1.
    Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc 290:199–206CrossRefGoogle Scholar
  2. 2.
    Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD (2004) Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 19:1379–1384CrossRefGoogle Scholar
  3. 3.
    Norwood VF (2003) Hypertension. Pediatr Rev 23:197–208CrossRefGoogle Scholar
  4. 4.
    Varda NM, Gregoric A (2005) A diagnostic approach to the child with hypertension. Pediatr Nephrol 20:499–506CrossRefGoogle Scholar
  5. 5.
    Rames LK, Clarke WR, Connor WE, Reiter MA, Lauer RM (1978) Normal blood pressure and evaluation of sustained blood pressure elevation in childhood: the Muscatine study. Pediatrics 61:245–251PubMedGoogle Scholar
  6. 6.
    Bartosh SM, Aronson AJ (1999) Childhood hypertension: an update on etiology, diagnosis, and treatment. Pediatr Clin North Am 46:235–252CrossRefGoogle Scholar
  7. 7.
    National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649–658Google Scholar
  8. 8.
    Arar MY, Hogg RJ, Arant BS Jr, Seikaly MG (1994) Etiology of sustained hypertension in children in southwestern United States. Pediatr Nephrol 8:186–189CrossRefGoogle Scholar
  9. 9.
    Flynn JT, Newburger JW, Daniels SR, Sanders SP, Portman RJ, Hogg RJ, Saul JP, PATH-1 Investigators (2004) A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr 145:353–359CrossRefGoogle Scholar
  10. 10.
    Flynn JT, Warnick SJ (2002) Isradipine treatment of hypertension in children: a single-center experience. Pediatr Nephrol 17:748–753CrossRefGoogle Scholar
  11. 11.
    Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S, Enalapril Pediatric Hypertension Collaborative Study Group (2002) A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 42:870–880CrossRefGoogle Scholar
  12. 12.
    Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S (2003) A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens 16:795–800CrossRefGoogle Scholar
  13. 13.
    Wuhl E, Mehls O, Schaefer F, ESCAPE Trial Group (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768–776CrossRefGoogle Scholar
  14. 14.
    Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C (2004) ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 19:222–226CrossRefGoogle Scholar
  15. 15.
    K/DOQI Clinical Practice Guidelines for Chronic Kidney Diseases: Evaluation, Classification, and Stratification (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Diseases: Evaluation, Classification, and Stratification. Am J Kidney Dis 39[Suppl 1]:S17–S21Google Scholar
  16. 16.
    Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ (2004) Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 113:475–482CrossRefGoogle Scholar
  17. 17.
    Tallian KB, Nahata MC, Turman MA, Mahan JD, Hayes JR, Mentser MI (1999) Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 13:304–310CrossRefGoogle Scholar
  18. 18.
    Park MK, Menard SW, Yuan C (2001) Comparison of ausculatory and oscillometric blood pressures. Arch Pediatr Adolesc Med 155:50–53CrossRefGoogle Scholar
  19. 19.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRefGoogle Scholar
  20. 20.
    Dekkers JC, Snieder H, Van Den Oord EJ, Treiber FA (2002) Moderators of blood pressure development from childhood to adulthood: a 10-year longitudinal study. J Pediatr 141:770–779CrossRefGoogle Scholar
  21. 21.
    Harshfield GA, Treiber FA, Wilson ME, Kapuku GK, Davis HC (2002) A longitudinal study of ethnic differences in ambulatory blood pressure patterns in youth. Am J Hypertens 15:525–530CrossRefGoogle Scholar
  22. 22.
    Berenson GS, Bogalusa Heart Study Investigators (2001) Bogalusa Heart Study: a long-term community study of a rural biracial (black/white) population. Am J Med Sci 322:267–274CrossRefGoogle Scholar
  23. 23.
    Silverstein DM, Palmer J, Baluarte HJ, Braas C, Conley SB, Polinsky MS (1999) Use of calcium-channel blockers in pediatric renal transplant recipients. Pediatr Transpl 3:288–292CrossRefGoogle Scholar
  24. 24.
    Rogan JW, Lyszkiewicz DA, Blowey D, Khattak S, Arbus GS, Koren G (2000) A randomized prospective crossover trial of amlodipine in pediatric hypertension. Pediatr Nephrol 14:1083–1087CrossRefGoogle Scholar
  25. 25.
    Wells T, Rippley R, Hogg R, Sakarcan A, Blowey D, Walson P, Vogt B, Delucchi A, Lo MW, Hand E, Panebianco D, Shaw W, Shahinfar S (2001) The pharmacokinetics of enalapril in children and infants with hypertension. J Clin Pharmacol 41:1064–1074CrossRefGoogle Scholar
  26. 26.
    Sinaiko AR, Mirkin BL, Hendrick DA, Green TP, O’Dea RF (1983) Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease. J Pediatr 103:799–805CrossRefGoogle Scholar
  27. 27.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ (2002) Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol 17:345–350CrossRefGoogle Scholar
  28. 28.
    Kaufmann MA, Pargger H, Drop LJ (1996) Oscillometric blood pressure measurements by different devices are not interchangeable. Anesth Analg 82:377–381PubMedGoogle Scholar
  29. 29.
    Cook NR, Gillman MW, Rosner BA, Taylor JO, Hennekens CH (2000) Combining annual blood pressure measurements in childhood to improve prediction of young adult blood pressure. Stat Med 19:2625–2640CrossRefGoogle Scholar
  30. 30.
    Burke V, Beilin LJ, Dunbar D (2001) Tracking of blood pressure in Australian children. J Hypertens 19:1185–1192CrossRefGoogle Scholar
  31. 31.
    Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S (2005) Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transpl 9:381–390CrossRefGoogle Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Douglas M. Silverstein
    • 1
    Email author
  • Edward Champoux
    • 2
  • Diego H. Aviles
    • 1
  • V. Matti Vehaskari
    • 1
  1. 1.Department of Pediatrics, Division of NephrologyLouisiana State University Health Sciences CenterNew OrleansUSA
  2. 2.Department of PediatricsKeesler Air Force BaseBiloxiUSA

Personalised recommendations